» Articles » PMID: 24160568

Effects of Aqueous Leaf Extract of Asystasia Gangetica on the Blood Pressure and Heart Rate in Male Spontaneously Hypertensive Wistar Rats

Overview
Publisher Biomed Central
Date 2013 Oct 29
PMID 24160568
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Asystasia gangentica (A. gangetica) belongs to the family Acanthaceae. It is used to treat hypertension, rheumatism, asthma, diabetes mellitus, and as an anthelmintic in South Africa, India, Cameroun, Nigeria, and Kenya respectively. It has also been reported to inhibit the angiotensin I converting enzyme (ACE) in-vitro. Therefore, the aim of this study is to investigate the in-vivo effect of aqueous leaf extract (ALE) of A. gangetica on the blood pressure (BP) and heart rate (HR) in anaesthetized male spontaneously hypertensive rats (SHR); and to elucidate possible mechanism(s) by which it acts.

Methods: The ALE of A. gangetica (10-400 mg/kg), angiotensin I human acetate salt hydrate (ANG I, 3.1-100 μg/kg) and angiotensin II human (ANG II, 3.1-50 μg/kg) were administered intravenously. The BP and HR were measured via a pressure transducer connecting the femoral artery to a Powerlab and a computer for recording.

Results: A. gangetica significantly (p<0.05), and dose-dependently reduced the systolic, diastolic, and mean arterial BP. The significant (p<0.05) reductions in HR were not dose-dependent. Both ANG I and ANG II increased the BP dose-dependently. Co-infusion of A. gangetica (200 mg/kg) with either ANG I or ANG II significantly (p<0.05) suppressed the hypertensive effect of both ANG I and ANG II respectively, and was associated with reductions in HR.

Conclusions: A. gangetica ALE reduced BP and HR in the SHR. The reduction in BP may be a result of actions of the ALE on the ACE, the ANG II receptors and the heart rate.

Citing Articles

South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia.

Reddy R, Baijnath S, Moodley R, Moodley J, Naicker T, Govender N J Ayurveda Integr Med. 2022; 13(2):100562.

PMID: 35675745 PMC: 9178479. DOI: 10.1016/j.jaim.2022.100562.


Awareness and Current Therapeutics of Asthma.

Zainab R, Akram M, Daniyal M, Riaz M Dose Response. 2019; 17(3):1559325819870900.

PMID: 31523203 PMC: 6728691. DOI: 10.1177/1559325819870900.


Long-term antihypertensive effects of far-infrared ray irradiated from wooden board in spontaneously hypertensive rats.

Lin C, Lin M, Chen Y, Lee K, Huang K, Chang S BMC Complement Altern Med. 2016; 16:57.

PMID: 26857237 PMC: 4745157. DOI: 10.1186/s12906-016-1040-1.

References
1.
Gurib-Fakim A . Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2005; 27(1):1-93. DOI: 10.1016/j.mam.2005.07.008. View

2.
Hearse D, Sutherland F . Experimental models for the study of cardiovascular function and disease. Pharmacol Res. 2000; 41(6):597-603. DOI: 10.1006/phrs.1999.0651. View

3.
Carvalho M, Romano-Lieber N, Bergsten-Mendes G, Secoli S, Ribeiro E, Lebrao M . Polypharmacy among the elderly in the city of São Paulo, Brazil - SABE Study. Rev Bras Epidemiol. 2013; 15(4):817-27. DOI: 10.1590/s1415-790x2012000400013. View

4.
Kobori H, Nangaku M, Navar L, Nishiyama A . The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59(3):251-87. DOI: 10.1124/pr.59.3.3. View

5.
Shimizu F, Kasai T, Takamata A . Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats. J Appl Physiol (1985). 2009; 106(6):1943-8. DOI: 10.1152/japplphysiol.90516.2008. View